These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 9108424
1. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Richardson DR, Milnes K. Blood; 1997 Apr 15; 89(8):3025-38. PubMed ID: 9108424 [Abstract] [Full Text] [Related]
2. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Richardson DR, Tran EH, Ponka P. Blood; 1995 Dec 01; 86(11):4295-306. PubMed ID: 7492790 [Abstract] [Full Text] [Related]
3. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs. Becker E, Richardson DR. J Lab Clin Med; 1999 Nov 01; 134(5):510-21. PubMed ID: 10560945 [Abstract] [Full Text] [Related]
4. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation. Darnell G, Richardson DR. Blood; 1999 Jul 15; 94(2):781-92. PubMed ID: 10397746 [Abstract] [Full Text] [Related]
5. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis. Richardson DR, Ponka P. J Lab Clin Med; 1994 Nov 15; 124(5):660-71. PubMed ID: 7964124 [Abstract] [Full Text] [Related]
6. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process. Richardson DR. Biochim Biophys Acta; 1997 May 16; 1320(1):45-57. PubMed ID: 9186779 [Abstract] [Full Text] [Related]
7. Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture. Baker E, Richardson D, Gross S, Ponka P. Hepatology; 1992 Mar 16; 15(3):492-501. PubMed ID: 1544632 [Abstract] [Full Text] [Related]
10. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Richardson D, Ponka P, Baker E. Cancer Res; 1994 Feb 01; 54(3):685-9. PubMed ID: 8306330 [Abstract] [Full Text] [Related]
13. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives. Tsafack A, Loyevsky M, Ponka P, Cabantchik ZI. J Lab Clin Med; 1996 Jun 01; 127(6):574-82. PubMed ID: 8648262 [Abstract] [Full Text] [Related]
14. Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells. Buss JL, Arduini E, Shephard KC, Ponka P. Biochem Pharmacol; 2003 Feb 01; 65(3):349-60. PubMed ID: 12527328 [Abstract] [Full Text] [Related]
15. Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone. Bláha K, Cikrt M, Nerudová J, Ponka HF. Blood; 1998 Jun 01; 91(11):4368-72. PubMed ID: 9596686 [Abstract] [Full Text] [Related]
18. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. Buss JL, Neuzil J, Gellert N, Weber C, Ponka P. Biochem Pharmacol; 2003 Jan 15; 65(2):161-72. PubMed ID: 12504792 [Abstract] [Full Text] [Related]
19. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action. Macková E, Hrušková K, Bendová P, Vávrová A, Jansová H, Hašková P, Kovaříková P, Vávrová K, Simůnek T. Chem Biol Interact; 2012 May 30; 197(2-3):69-79. PubMed ID: 22521999 [Abstract] [Full Text] [Related]
20. Analogues of pyridoxal isonicotinoyl hydrazone (PIH) as potential iron chelators for the treatment of neoplasia. Richardson DR. Leuk Lymphoma; 1998 Sep 30; 31(1-2):47-60. PubMed ID: 9720714 [Abstract] [Full Text] [Related] Page: [Next] [New Search]